Please wait a minute...


China Biotechnology
China Biotechnology  2013, Vol. 33 Issue (10): 36-43    DOI:
Expression of Herpes Simplex Virus Type 2 Latency-associated Transcript Open Reading Frames and Its Anti-apoptotic Effects
ZHONG Fei-fei1,2, YANG Hui-lan1, LÜ Fang-biao1,2, XUE Li-zhang1,2, BAI Li-li1,2, FAN Jian-yong1
1. Department of Dermatology, Guangzhou Liuhuaqiao Hospital, Guangzhou 510010, China;
2. School of Biological Science and Engineering, South China University of Technology, Guangzhou 510006, China
Download:   PDF(1196KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Objective:To study the effects of herpes simplex virus type 2(HSV-2) latency-associated transcript(LAT) open reading frames(ORFs) on Vero cells which were induced apoptosis by agent. Methods:PCR amplified LAT ORF1, ORF2, ORF3 fragment,then construct recombinant plasmid pEGFP-ORF1,pEGFP-ORF2,pEGFP-ORF3,transfect them into Vero cells and identify its expression by RT-PCR.Using actinomycin D,5-FU and cisplatinere to induce Vero cells apoptosis,the changes of Vero cells morphology was observed by fluorescence microscopy.MTT assay was used to evaluate Vero cells viability and flow cytometry was used to calculate the cells apoptosis rate. Results:The pEGFP-ORF1,pEGFP-ORF2,pEGFP-ORF3 was constructed successfully which was confirmed by Double digestion and sequencing. Vero cells morphology were normal when transfected with pEGFP-ORFs and induced by apoptosis-inducing agent. MTT assay showed that the viabilities of Vero cells in recombinant plasmid group were no significant difference compared with the normal control group(P> 0.05), but remarkable higher than empty plasmid pEGFP-C2 group,the difference was significant(P<0.05).Flow cytometry assay showed that the cells apoptosis rate in pEGFP-ORFs group were no significant difference compared with the normal control group(P> 0.05),but was remarkable lower than the pEGFP-C2 group(P<0.05). Conclusion HSV-2 LAT ORFs gene can effectively expressed in Vero cells and can protect Vero cells from apoptosis.

Key wordsORFs      Herpes simplex virus      LAT      Apoptosis-inducing agent      Apoptosis      Vero cells     
Received: 19 July 2013      Published: 25 October 2013
ZTFLH:  Q819  
Cite this article:

ZHONG Fei-fei, YANG Hui-lan, LÜ Fang-biao, XUE Li-zhang, BAI Li-li, FAN Jian-yong. Expression of Herpes Simplex Virus Type 2 Latency-associated Transcript Open Reading Frames and Its Anti-apoptotic Effects. China Biotechnology, 2013, 33(10): 36-43.

URL:     OR

[1] Brinkman K K, Mishra P, Fraser N W. The half-life of the HSV-1 1.5-kb LAT intron is similar to the half-life of the 2.0-kb LAT intron. J Neurovirol, 2013, 19 (1): 102-108.
[2] Kent J R, Kang W, Miller C G, et al. Herpes simplex virus latency-associated transcript gene function. J Neurovirol, 2003, 9(3): 285-290.
[3] Kather A,Raftery M J,Devi-Rao G,et al.Herpes Simplex Virus Type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.J Virol, 2010, 84(2): 1034- 1046.
[4] Du T, Zhou G,Roizman B,et al.HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc Natl Acad Sci U S A,2011, 108(26): 18820-18824.
[5] Sun L, Li Q. The miRNAs of herpes simplex virus (HSV). Virol Sin,2012,27(6)333-338.
[6] Johnston C,Saracino M,Kuntz S,et al.Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation:three randomised,open-label,cross-over trials. Lancet,2012,379(9816):641-647.
[7] Krause P R, Ostrove J M, Straus S E. The nucleotide sequence,5’ end,promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript. J Virol,1991, 65(10): 5619-5623.
[8] Li S,Carpenter D,Hsiang C,et al.Herpes simplex virus type 1 latency-associated transcript inhibits apoptosis and promotes neurite sprouting in neuroblastoma cells following serum starvation by maintaining protein kinase B (AKT) levels. J Gen Virol,2010,91(Pt 4):858-866.
[9] Jiang X Z,Chentoufi A A,Hsiang C H,et al.The Herpes Simplex Virus Type 1 latency-associated transcript can protect neuron-derived C1300 and neuro2A cells from granzyme B-induced apoptosis and CD8 T-Cell killing.J Virol,2011,85(5):2325-2332.
[10] Stefanidou M, Ramos I, Mas C V, et al.Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy.J Virol,2013,87(3):1443-1453.
[11] Ogawa Y, Kawamura T, Matsuzawa T, et al.Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.Cell Host Microbe,2013,13(1):77-86.
[12] Aziz A C,Xavier D,Pierre-Alain R,et al.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Curr Trends Immunol,2012,13:51-68.
[13] Carpenter D,Henderson G, Hsiang C,et al.Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity.Microb Pathog,2008,44(2):98-102.
[14] Thomas S K,Gough G,Latchman D S.A protein encoded by the herpes simplex virus(HSV) type 1 2-kilobase latency-associated transcript is phosphorylated,localized to the nucleus,and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome.J Virol,2002, 76(8): 4056-406.
[15] Jin L, Perng G C, Mott K R, et al. A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse. J Virol,2005,79(19):12286-12295.
[16] Bertke A S, Apakupakul K, Ma A, et al. LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans. PLoS One,2012,7(12):e53281.
[1] YUAN Xiao-chuan, LIAN Fang, ZHAO Yin-nong, CHEN Chuang, HUANG Shan, LI Ke-zhi, ZENG Ai-ping, HE Jian-bo, WU Guo-bin. Elevated Temperature Induced Acceleration of Electrophoretic Tissue Clearing Process of Rat Liver Tissue[J]. China Biotechnology, 2017, 37(9): 65-70.
[2] LIU Cui-cui, HU Meng-die, WANG Zhi, DAI Jun, YAO Juan, LI Pei, LI Zhi-jun, CHEN Xiong, LI Xin. Metabolic Characteristics of Intracellular Trehalose Accumulation in Zygosaccharomyces rouxii[J]. China Biotechnology, 2017, 37(9): 41-47.
[3] LAI Mu-lan, CHEN Xie-lan. Devolopment of Regulation of Protein Lysine Acetylation on Intermediate Metabolism[J]. China Biotechnology, 2017, 37(9): 126-133.
[4] GUO Zhong-ping, XU Li. Revision of the General Policies of Nomenclature for Biological Products in China[J]. China Biotechnology, 2017, 37(8): 110-118.
[5] DAI Li-ting, WU Zhong-nan, HUANG Xiang, YANG Jie, ZENG Hui-lan, WANG Guo-cai, JIANG Jian-wei. Molecular Mechanism of Inducing GLC-82 Cells Apoptosis by Ethanol Extract from Wedelia prostrate( Arn.) Hemsl[J]. China Biotechnology, 2017, 37(8): 1-7.
[6] XU An-jian, LI Yan-meng, LI Si-wen, WU Shan-na, ZHANG Bei, HUANG Jian. The Effect of PHP14 Knockdown on Lung Cancer Cells Apoptosis and Its Mechanism[J]. China Biotechnology, 2017, 37(7): 12-17.
[7] QIN Rui-ping, LI Ling-xia, MA Xiao-ling, XI Ou-yan, ZHAO Ting, QIU Ling-ling, LI Jiang-wei. Inhibition of Osteoporosis in Ovariectomized Rats Using Follicle-stimulating Hormone Receptor Specific Polyclonal Antibody[J]. China Biotechnology, 2017, 37(6): 9-16.
[8] LI Yan-wei, MA Yi, HAN Lei, XIAO Xing, DANG Shi-ying, WEN Tao, WANG De-hua, FAN Zhi-yong. A Preliminary Study on Fas Apoptosis Inhibitory Molecule FAIM 1 Inducing and Simple Obesity[J]. China Biotechnology, 2017, 37(6): 37-42.
[9] ZHAO Xiu-li, ZHOU Dan-dan, YAN Xiao-guang, WU Hao, CAIYIN Qing-gele, LI Yan-ni, QIAO Jian-jun. Regulation and Application in Metabolic Engineering of Bacterial Small RNAs[J]. China Biotechnology, 2017, 37(6): 97-106.
[10] WANG De-hua, MA Yi, HAN Lei, XIAO Xing, LI Yan-wei, DANG Shi-ying, FAN Zhi-yong, WEN Tao, HONG An. Preparation of Novel Recombinant PACAP Derivative MPL-2 and Its Effect on Anti-type 2 Diabetes Mellitus[J]. China Biotechnology, 2017, 37(5): 59-65.
[11] XU Yun-qiao, LI Ting-ting, WU Cai-e, FAN Gong-jian, LI Tong. Research Progress on the Methods of Deglycosylation of Glycoproteins[J]. China Biotechnology, 2017, 37(5): 97-106.
[12] LI Min, WU Ri-wei. The Analysis of Coagulation Factors Market[J]. China Biotechnology, 2017, 37(5): 133-139.
[13] BAI Xin-yan, WEN Li-min, WANG Yu-jing, WANG Hai-long, XIE Jun, GUO Rui. ANKRD49 Inhibits UV-induced Apoptosis of GC-1 Cells by Up-regulating Bcl-xL[J]. China Biotechnology, 2017, 37(4): 40-47.
[14] DAI Jian-lu, LU Zhi-li, LIN Ling, WANG Yi-guang, HE Wei-qing. Construction of the Isomycin I High-yield Strain by Introducing a Heterologous Positive Regulatory Gene acyB2[J]. China Biotechnology, 2017, 37(3): 65-72.
[15] WANG Xiao-li, YU Qing, YUAN Ya-hong, TENG Zhi-ping, LI Dong-sheng, ZENG Yi. Targeting TRIM5α Gene of CD4+ T cells of Macaca mulatta Affect Their Ability on HIV Infection[J]. China Biotechnology, 2017, 37(2): 15-19.